Hackensack Meridian Health, Inc. (HMH)

Hackensack Meridian Health, Inc. (HMH)

Hackensack Meridian Health functions as an asset owner through its endowment and foundation structures. The health network was formed to consolidate hospital operations across New Jersey. Its primary philanthropic vehicle, the Hackensack Meridian Health Foundation, was established in 2016 and manages fundraising and endowment distributions. The portfolio mixes public equity holdings with private healthcare investments. Confirmed public positions include SPDR S&P 500 ETF Trust, iShares MSCI EAFE ETF, and iShares Russell 1000 Growth ETF. Private holdings include Canary Speech, EpiBone, and EValuate Diagnostics, accessed via the Bear's Den Innovation Program and the Center for Discovery and Innovation. Geographic exposure centers on the United States with additional international equity allocations. Total consolidated assets reached $7.6 billion according to recent disclosures. The organization maintains its headquarters in Edison, New Jersey, and operates additional facilities including Hackensack University Medical Center and Jersey Shore University Medical Center. It sponsors the Hackensack Meridian Health Foundation Annual Gala and participates in the Association for Healthcare Philanthropy. May 2026: Hosted the Annual HMHRI Research Symposium focused on emerging technologies. HMH separates its investment activities from clinical operations through distinct legal entities and program vehicles. The structure allows direct co-investments alongside external partners while the foundation handles endowment governance and grant-making.